Happy with Covaxin clinical trials: Belagavi doctor Dr Amit Bhate

The vaccine has been given to over 26,000 people in the country. No side effects have been reported yet.

Published: 04th January 2021 02:42 AM  |   Last Updated: 04th January 2021 06:07 AM   |  A+A A-

'COVAXIN' was developed and manufactured at the company's Bio-safety Level-III high containment facility at Genome Valley.

It may be recalled that Covaxin is India's indigenous COVID-19 vaccine candidate. (Photo| Special Arrangement)

By Express News Service

BELAGAVI: Expressing happiness about the positive results of the clinical trials of Covaxin, Dr Amit Bhate of Jeevan Rekha Hospital said, “The Central government’s decision to use this vaccine has made us happy.”

Speaking to media persons on Sunday, he said, “Covaxin has been developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR). Covishield has been developed in Pune and has been approved by the Drug Controller General of India. This news has brought a lot of happiness, as months of efforts yielded fruits.”

The vaccine has been given to over 26,000 people in the country. No side effects have been reported yet.

The clinical trials of Covaxin had been conducted in three phases at Jeevan Rekha hospital in Belagavi.

A total of 54 volunteers participated in the first two phases of trials and 2,000 volunteers participated in the third phase.

“We have received positive results during these trials as a good number of anti-bodies developed in those participating. No side effects have been reported so far. We are preparing to vaccinate 2,000 more people as we have got got emergency permission,” Dr Bhate said.

Now we are on Telegram too. Follow us for updates
India Matters

Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

Videos
Gallery